Literature DB >> 9786723

Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease.

P Rutgeerts, S Vermeire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9786723     DOI： 10.1016/s0016-5085(98)70274-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

Review 1.  Diagnostic methodologies: serology, endoscopy, and radiology.

Authors:  T Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2001-12

2.  Soluble ST2: a new and promising activity marker in ulcerative colitis.

Authors:  David Díaz-Jiménez; Lucía E Núñez; Caroll J Beltrán; Enzo Candia; Cristóbal Suazo; Manuel Alvarez-Lobos; María-Julieta González; Marcela A Hermoso; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

3.  Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.

Authors:  Charles Noah Bernstein; Hani El-Gabalawy; Michael Sargent; Carol Landers; Patricia Rawsthorne; Brenda Elias; Stephan R Targan
Journal:  Can J Gastroenterol       Date:  2011-05       Impact factor: 3.522

4.  Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries.

Authors:  E Jensen-Jarolim; C Neumann; G Oberhuber; R Gscheidlinger; C Neuchrist; W Reinisch; R I Zuberi; E Penner; F T Liu; G Boltz-Nitulescu
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

5.  Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.

Authors:  Troy D Jaskowski; Christine M Litwin; Harry R Hill
Journal:  Clin Vaccine Immunol       Date:  2006-06

6.  Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress.

Authors:  Robert G Maunder; Gordon R Greenberg; Jonathan J Hunter; William J Lancee; A Hillary Steinhart; Mark S Silverberg
Journal:  Am J Gastroenterol       Date:  2006-10-04       Impact factor: 10.864

7.  Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients.

Authors:  Ira Shafran; Christopher Piromalli; Jonathan W Decker; Javier Sandoval; Saleh A Naser; Fouad A K El-Zaatari
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

8.  Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.

Authors:  Govind K Makharia; Vikas Sachdev; Rajiva Gupta; Suman Lal; R M Pandey
Journal:  Dig Dis Sci       Date:  2006-12-08       Impact factor: 3.487

9.  Target antigens for perinuclear antineutrophil cytoplasmic antibodies in Iranian patients with ulcerative colitis.

Authors:  Ali Bahari; Mahmoud Aarabi; Mehdi Hedayati; Ali Jarollahi; Farzad Firouzi; Rahim Aghazadeh; Mohammad Reza Zali; Zohreh Bari; Mohammad Hashemi; Abbas Esmaeilzadeh; Ali Mokhtarifar; Azita Ganji
Journal:  Middle East J Dig Dis       Date:  2014-10

10.  Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.

Authors:  Fang Yao; Yihong Fan; Bin Lv; Conghua Ji; Li Xu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.